Targeting Interleukin 13 for the Treatment of Atopic Dermatitis

Atopic dermatitis (AD) is a common chronic inflammatory skin condition that has a significant impact on a patient’s quality of life and requires ongoing management. Conventional topical and systemic therapies do not target specific components of AD pathogenesis and, therefore, have limited efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lytvyn, Yuliya, Gooderham, Melinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966769/
https://www.ncbi.nlm.nih.gov/pubmed/36839890
http://dx.doi.org/10.3390/pharmaceutics15020568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966769/
https://www.ncbi.nlm.nih.gov/pubmed/36839890
http://dx.doi.org/10.3390/pharmaceutics15020568

Ejemplares similares